Tempest Therapeutics, Inc. Proceeds from Common Stock Issued
Tempest Therapeutics, Inc. (TPST) reported Proceeds from Common Stock Issued of $6.04 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-30
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $1.03M, a 94.88% decline year-over-year.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-06-30 was $3.57M, a 21.66% decline year-over-year.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for the quarter ending 2025-03-31 was $1.44M, a 470.36% increase year-over-year.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2025 was $6.04M, a 78.86% decline from fiscal 2024.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2024 was $28.59M, a 19.69% decline from fiscal 2023.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2023 was $35.60M, a 301.78% increase from fiscal 2022.
- Tempest Therapeutics, Inc. proceeds from issuance of common stock for fiscal 2022 was $8.86M, a 73.49% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 11 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed | Proceeds from Issuance of Common Stock 15 month | Proceeds from Issuance of Common Stock 18 month | Proceeds from Issuance of Common Stock 21 month | Proceeds from Issuance of Common Stock 24 month | Proceeds from Issuance of Common Stock 27 month | Proceeds from Issuance of Common Stock 30 month | Proceeds from Issuance of Common Stock 33 month | Proceeds from Issuance of Common Stock 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.03M derived: sum of 2 quarters · filed 2026-03-30 | $4.60M derived: sum of 3 quarters · filed 2026-03-30 | $6.04M 10-K · filed 2026-03-30 | |||||||||||||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.57M derived: sum of 2 quarters · filed 2025-11-05 | $5.01M 10-Q · filed 2025-11-05 | $25.16M derived: sum of 4 quarters · filed 2026-03-30 | |||||||||||||||
| 2025-06-30 | $3.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $5.01M 10-Q · filed 2025-08-11 | $25.16M derived: sum of 3 quarters · filed 2026-03-30 | $28.79M derived: sum of 4 quarters · filed 2026-03-30 | |||||||||||||||
| 2025-03-31 | $1.44M 10-Q · filed 2025-05-13 | $21.59M derived: sum of 2 quarters · filed 2026-03-30 | $25.22M derived: sum of 3 quarters · filed 2026-03-30 | $29.78M derived: sum of 4 quarters · filed 2026-03-30 | |||||||||||||||
| 2024-12-31 | $20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $23.78M derived: sum of 2 quarters · filed 2026-03-30 | $28.34M derived: sum of 3 quarters · filed 2026-03-30 | $28.59M 10-K · filed 2026-03-30 | |||||||||||||||
| 2024-09-30 | $3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.19M derived: sum of 2 quarters · filed 2025-11-05 | $8.44M 10-Q · filed 2025-11-05 | $42.79M derived: sum of 4 quarters · filed 2025-11-05 | |||||||||||||||
| 2024-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $4.81M 10-Q · filed 2025-08-11 | $39.16M derived: sum of 3 quarters · filed 2025-08-11 | $39.18M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||||
| 2024-03-31 | $253.00K 10-Q · filed 2025-05-13 | $34.60M derived: sum of 2 quarters · filed 2025-05-13 | $34.62M derived: sum of 3 quarters · filed 2025-05-13 | $35.81M derived: sum of 4 quarters · filed 2025-05-13 | |||||||||||||||
| 2023-12-31 | $34.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $34.37M derived: sum of 2 quarters · filed 2025-03-27 | $35.56M derived: sum of 3 quarters · filed 2025-03-27 | $35.60M 10-K · filed 2025-03-27 | |||||||||||||||
| 2023-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.21M derived: sum of 2 quarters · filed 2024-11-12 | $1.25M 10-Q · filed 2024-11-12 | $1.26M derived: sum of 4 quarters · filed 2024-11-12 | |||||||||||||||
| 2023-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.23M 10-Q · filed 2024-08-08 | $1.24M derived: sum of 3 quarters · filed 2024-08-08 | $1.59M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||||
| 2023-03-31 | $44.00K 10-Q · filed 2024-05-09 | $56.00K derived: sum of 2 quarters · filed 2024-05-09 | $407.00K derived: sum of 3 quarters · filed 2024-05-09 | $7.50M derived: sum of 4 quarters · filed 2024-05-09 | |||||||||||||||
| 2022-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $363.00K derived: sum of 2 quarters · filed 2024-03-19 | $7.46M derived: sum of 3 quarters · filed 2024-03-19 | $8.86M 10-K · filed 2024-03-19 | |||||||||||||||
| 2022-09-30 | $351.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.45M derived: sum of 2 quarters · filed 2023-11-08 | $8.85M 10-Q · filed 2023-11-08 | $8.80M derived: sum of 4 quarters · filed 2023-11-08 | |||||||||||||||
| 2022-06-30 | $7.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $8.50M 10-Q · filed 2023-08-10 | $8.45M derived: sum of 3 quarters · filed 2023-08-10 | $11.91M derived: sum of 4 quarters · filed 2023-08-10 | |||||||||||||||
| 2022-03-31 | $1.40M 10-Q · filed 2023-05-10 | $1.35M derived: sum of 2 quarters · filed 2023-05-10 | $4.82M derived: sum of 3 quarters · filed 2023-05-10 | $34.83M derived: sum of 4 quarters · filed 2023-05-10 | |||||||||||||||
| 2021-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.42M derived: sum of 2 quarters · filed 2023-03-22 | $33.42M derived: sum of 3 quarters · filed 2023-03-22 | $33.42M 10-K · filed 2023-03-22 | |||||||||||||||
| 2021-09-30 | $3.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $33.47M derived: sum of 2 quarters · filed 2022-11-08 | $33.47M 10-Q · filed 2022-11-08 | $33.47M derived: sum of 4 quarters · filed 2022-11-08 | |||||||||||||||
| 2021-06-30 | $30.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $30.01M 10-Q · filed 2022-08-15 | $30.01M derived: sum of 3 quarters · filed 2022-08-15 | $30.01M derived: sum of 4 quarters · filed 2022-08-15 | |||||||||||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-13 | $0.00 derived: sum of 2 quarters · filed 2022-05-13 | $0.00 derived: sum of 3 quarters · filed 2022-05-13 | -$5.52M derived: sum of 4 quarters · filed 2022-05-13 | |||||||||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | -$5.52M derived: sum of 3 quarters · filed 2022-03-29 | $0.00 10-K · filed 2022-03-29 | $5.45M 10-K · filed 2021-03-29 | ||||||||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$5.52M derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $5.65M 10-Q · filed 2020-11-09 | $26.69M derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||||
| 2020-06-30 | -$5.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $5.65M 10-Q · filed 2020-08-10 | $26.69M derived: sum of 3 quarters · filed 2021-08-12 | $26.69M derived: sum of 4 quarters · filed 2021-08-12 | ||||||||||||||
| 2020-03-31 | $5.52M 10-Q · filed 2021-05-13 | $5.72M 10-Q · filed 2020-05-08 | $32.21M derived: sum of 2 quarters · filed 2021-05-13 | $32.21M derived: sum of 3 quarters · filed 2021-05-13 | $32.21M derived: sum of 4 quarters · filed 2021-05-13 | ||||||||||||||
| 2019-12-31 | $26.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $26.69M derived: sum of 2 quarters · filed 2021-03-29 | $26.69M derived: sum of 3 quarters · filed 2021-03-29 | $26.69M 10-K · filed 2021-03-29 | |||||||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $0.00 10-Q · filed 2020-11-09 | ||||||||||||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | |||||||||||||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | ||||||||||||||||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-11 | ||||||||||||||||||
| 2018-12-07 | $18.70M 10-K · filed 2020-03-11 | ||||||||||||||||||
| 2018-12-06 | $21.50M 10-K · filed 2020-03-11 | ||||||||||||||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 | ||||||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |||||||||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | ||||||||||||||||||
| 2016-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$24.00K derived: sum of 2 quarters · filed 2018-03-15 | $53.92M derived: sum of 3 quarters · filed 2018-03-15 | $53.92M 10-K · filed 2018-03-15 | |||||||||||||||
| 2016-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $53.93M derived: sum of 2 quarters · filed 2017-11-02 | $53.93M 10-Q · filed 2017-11-02 | $53.93M derived: sum of 4 quarters · filed 2018-03-15 | |||||||||||||||
| 2016-06-30 | $53.90M 10-K · filed 2018-03-15 | $53.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $53.95M 10-Q · filed 2017-08-03 | $53.95M derived: sum of 3 quarters · filed 2018-03-15 | $53.95M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $0.00 derived: sum of 4 quarters · filed 2018-03-15 | |||||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 derived: sum of 2 quarters · filed 2018-03-15 | $0.00 derived: sum of 3 quarters · filed 2018-03-15 | $124.06M 10-K · filed 2018-03-15 | |||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $124.06M 10-Q · filed 2016-11-03 | $124.24M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||||||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $124.06M 10-Q · filed 2016-08-04 | $124.24M derived: sum of 3 quarters · filed 2017-03-02 | $124.16M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||||||||
| 2015-03-31 | $124.06M 10-Q · filed 2016-05-05 | $124.24M derived: sum of 2 quarters · filed 2017-03-02 | $124.16M derived: sum of 3 quarters · filed 2017-03-02 | $124.14M derived: sum of 4 quarters · filed 2017-03-02 | |||||||||||||||
| 2015-01-31 | $124.10M 10-K · filed 2018-03-15 | ||||||||||||||||||
| 2014-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $94.00K derived: sum of 2 quarters · filed 2017-03-02 | $72.00K derived: sum of 3 quarters · filed 2017-03-02 | $51.73M 10-K · filed 2017-03-02 | |||||||||||||||
| 2014-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$107.00K derived: sum of 2 quarters · filed 2015-11-05 | $51.55M 10-Q · filed 2015-11-05 | $51.48M derived: sum of 4 quarters · filed 2016-02-26 | |||||||||||||||
| 2014-06-30 | -$22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $51.64M 10-Q · filed 2015-08-10 | $51.56M derived: sum of 3 quarters · filed 2016-02-26 | $51.40M derived: sum of 4 quarters · filed 2016-02-26 | |||||||||||||||
| 2014-03-31 | $51.70M 10-K · filed 2017-03-02 | $51.66M 10-Q · filed 2015-05-11 | $51.59M derived: sum of 2 quarters · filed 2016-02-26 | $51.42M derived: sum of 3 quarters · filed 2016-02-26 | $51.42M derived: sum of 4 quarters · filed 2016-02-26 | $88.12M 10-Q · filed 2014-05-08 | |||||||||||||
| 2013-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$240.00K derived: sum of 2 quarters · filed 2016-02-26 | -$238.00K derived: sum of 3 quarters · filed 2016-02-26 | $32.41M 10-K · filed 2016-02-26 | $36.45M 10-K · filed 2014-02-27 | ||||||||||||||
| 2013-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$164.00K derived: sum of 2 quarters · filed 2014-11-10 | $32.49M 10-Q · filed 2014-11-10 | $32.47M derived: sum of 4 quarters · filed 2015-03-16 | $36.53M 10-Q · filed 2013-11-13 | ||||||||||||||
| 2013-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $32.65M 10-Q · filed 2014-08-07 | $32.64M derived: sum of 3 quarters · filed 2015-03-16 | $36.69M derived: sum of 4 quarters · filed 2015-03-16 | $36.70M 10-Q · filed 2013-08-13 | ||||||||||||||
| 2013-03-31 | $32.70M 10-K · filed 2016-02-26 | $32.65M 10-Q · filed 2014-05-08 | $32.64M derived: sum of 2 quarters · filed 2015-03-16 | $36.69M derived: sum of 3 quarters · filed 2015-03-16 | $36.69M 10-Q · filed 2013-05-15 | ||||||||||||||
| 2012-12-31 | -$16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $4.04M derived: sum of 2 quarters · filed 2015-03-16 | $4.04M 10-K · filed 2015-03-16 | $4.04M 10-K · filed 2013-02-25 | |||||||||||||||
| 2012-09-30 | $4.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $4.05M 10-Q · filed 2013-11-13 | $4.06M 10-Q · filed 2012-11-13 | ||||||||||||||||
| 2012-06-30 | $1.00K 10-Q · filed 2013-08-13 | $3.00K 10-Q · filed 2012-08-14 | |||||||||||||||||
| 2011-12-31 | $2.00K 10-K · filed 2014-02-27 | ||||||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-13 | $2.00K 10-Q · filed 2012-11-13 | |||||||||||||||||
| 2011-06-30 | $2.00K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |